Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry

Abstract Background Severe asthma (SA) may require frequent courses or chronic use of oral corticosteroids (OCS), inducing many known side effects and complications. Therefore, it is important to identify risk factors of chronic use of OCS in SA, considering the heterogeneity of clinical and inflamm...

Full description

Bibliographic Details
Main Authors: S. Graff, S. Vanwynsberghe, G. Brusselle, S. Hanon, C. Sohy, L. J. Dupont, R. Peche, A. Michils, C. Pilette, G. Joos, R. E. Louis, F. N. Schleich
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Respiratory Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12931-020-01460-7
id doaj-9bea36f896fd490eae8cd4b61fbbe919
record_format Article
spelling doaj-9bea36f896fd490eae8cd4b61fbbe9192020-11-25T03:46:11ZengBMCRespiratory Research1465-993X2020-08-0121111110.1186/s12931-020-01460-7Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registryS. Graff0S. Vanwynsberghe1G. Brusselle2S. Hanon3C. Sohy4L. J. Dupont5R. Peche6A. Michils7C. Pilette8G. Joos9R. E. Louis10F. N. Schleich11Department of Respiratory Medicine, Ghent University HospitalDepartment of Respiratory Medicine, Ghent University HospitalDepartment of Respiratory Medicine, Ghent University HospitalRespiratory Division, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB)Department of Respiratory Medicine, Centre Hospitalier Universitaire UCL Namur, Université Catholique de LouvainDepartment of Respiratory Medicine, Katholieke Universiteit LeuvenDepartment of Respiratory Medicine, CHU-Charleroi, A. Vésale HospitalChest Department, Erasme University Hospital, Université Libre de BruxellesCliniques Universitaires St-Luc and Institute of Experimental and Clinical Research, Université Catholique de LouvainRespiratory Division, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB)Department of Respiratory Medicine, CHU Sart-Tilman, I3GIGA Research Group, University of LiegeDepartment of Respiratory Medicine, CHU Sart-Tilman, I3GIGA Research Group, University of LiegeAbstract Background Severe asthma (SA) may require frequent courses or chronic use of oral corticosteroids (OCS), inducing many known side effects and complications. Therefore, it is important to identify risk factors of chronic use of OCS in SA, considering the heterogeneity of clinical and inflammatory asthma phenotypes. Another aim of the present analysis is to characterize a subpopulation of severe asthmatics, in whom blood eosinophil counts (BEC) remain elevated despite chronic OCS treatment. Methods In a cross-sectional analysis of 982 SA patients enrolled in the Belgian Severe Asthma Registry (BSAR) between March 2009 and February 2019, we investigated the characteristics of the OCS treated patients with special attention to their inflammatory profile. Results At enrollment, 211 (21%) SA patients were taking maintenance OCS (median dose: 8 [IQR: 5–10]) mg prednisone equivalent). BEC was high (> 400/mm3) in 44% of the OCS treated population. Multivariable logistic regression analysis showed that risk factors for chronic use of OCS in SA were late-onset asthma (i.e. age of onset > 40 yr), frequent exacerbations (i.e. ≥2 exacerbations in the previous year) and non-atopic asthma. Late-onset asthma was also a predictor for persistently high BEC in OCS treated SA patients. Conclusion These data showed a significant association between a persistently high BEC and late-onset asthma in OCS treated SA patients. Whether it is poor compliance to treatment or corticosteroid insensitivity the reasons for this association warrants further investigation.http://link.springer.com/article/10.1186/s12931-020-01460-7AsthmaBlood eosinophilsOral corticosteroids
collection DOAJ
language English
format Article
sources DOAJ
author S. Graff
S. Vanwynsberghe
G. Brusselle
S. Hanon
C. Sohy
L. J. Dupont
R. Peche
A. Michils
C. Pilette
G. Joos
R. E. Louis
F. N. Schleich
spellingShingle S. Graff
S. Vanwynsberghe
G. Brusselle
S. Hanon
C. Sohy
L. J. Dupont
R. Peche
A. Michils
C. Pilette
G. Joos
R. E. Louis
F. N. Schleich
Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry
Respiratory Research
Asthma
Blood eosinophils
Oral corticosteroids
author_facet S. Graff
S. Vanwynsberghe
G. Brusselle
S. Hanon
C. Sohy
L. J. Dupont
R. Peche
A. Michils
C. Pilette
G. Joos
R. E. Louis
F. N. Schleich
author_sort S. Graff
title Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry
title_short Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry
title_full Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry
title_fullStr Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry
title_full_unstemmed Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry
title_sort chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the belgian severe asthma registry
publisher BMC
series Respiratory Research
issn 1465-993X
publishDate 2020-08-01
description Abstract Background Severe asthma (SA) may require frequent courses or chronic use of oral corticosteroids (OCS), inducing many known side effects and complications. Therefore, it is important to identify risk factors of chronic use of OCS in SA, considering the heterogeneity of clinical and inflammatory asthma phenotypes. Another aim of the present analysis is to characterize a subpopulation of severe asthmatics, in whom blood eosinophil counts (BEC) remain elevated despite chronic OCS treatment. Methods In a cross-sectional analysis of 982 SA patients enrolled in the Belgian Severe Asthma Registry (BSAR) between March 2009 and February 2019, we investigated the characteristics of the OCS treated patients with special attention to their inflammatory profile. Results At enrollment, 211 (21%) SA patients were taking maintenance OCS (median dose: 8 [IQR: 5–10]) mg prednisone equivalent). BEC was high (> 400/mm3) in 44% of the OCS treated population. Multivariable logistic regression analysis showed that risk factors for chronic use of OCS in SA were late-onset asthma (i.e. age of onset > 40 yr), frequent exacerbations (i.e. ≥2 exacerbations in the previous year) and non-atopic asthma. Late-onset asthma was also a predictor for persistently high BEC in OCS treated SA patients. Conclusion These data showed a significant association between a persistently high BEC and late-onset asthma in OCS treated SA patients. Whether it is poor compliance to treatment or corticosteroid insensitivity the reasons for this association warrants further investigation.
topic Asthma
Blood eosinophils
Oral corticosteroids
url http://link.springer.com/article/10.1186/s12931-020-01460-7
work_keys_str_mv AT sgraff chronicoralcorticosteroidsuseandpersistenteosinophiliainsevereasthmaticsfromthebelgiansevereasthmaregistry
AT svanwynsberghe chronicoralcorticosteroidsuseandpersistenteosinophiliainsevereasthmaticsfromthebelgiansevereasthmaregistry
AT gbrusselle chronicoralcorticosteroidsuseandpersistenteosinophiliainsevereasthmaticsfromthebelgiansevereasthmaregistry
AT shanon chronicoralcorticosteroidsuseandpersistenteosinophiliainsevereasthmaticsfromthebelgiansevereasthmaregistry
AT csohy chronicoralcorticosteroidsuseandpersistenteosinophiliainsevereasthmaticsfromthebelgiansevereasthmaregistry
AT ljdupont chronicoralcorticosteroidsuseandpersistenteosinophiliainsevereasthmaticsfromthebelgiansevereasthmaregistry
AT rpeche chronicoralcorticosteroidsuseandpersistenteosinophiliainsevereasthmaticsfromthebelgiansevereasthmaregistry
AT amichils chronicoralcorticosteroidsuseandpersistenteosinophiliainsevereasthmaticsfromthebelgiansevereasthmaregistry
AT cpilette chronicoralcorticosteroidsuseandpersistenteosinophiliainsevereasthmaticsfromthebelgiansevereasthmaregistry
AT gjoos chronicoralcorticosteroidsuseandpersistenteosinophiliainsevereasthmaticsfromthebelgiansevereasthmaregistry
AT relouis chronicoralcorticosteroidsuseandpersistenteosinophiliainsevereasthmaticsfromthebelgiansevereasthmaregistry
AT fnschleich chronicoralcorticosteroidsuseandpersistenteosinophiliainsevereasthmaticsfromthebelgiansevereasthmaregistry
_version_ 1724507301165924352